.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Queensland Health
Daiichi Sankyo
Cipla
Teva
Boehringer Ingelheim
Julphar
Moodys
UBS
Harvard Business School

Generated: June 27, 2017

DrugPatentWatch Database Preview

GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE Drug Profile

« Back to Dashboard

Which patents cover Guaifenesin And Dextromethorphan Hydrobromide, and what generic Guaifenesin And Dextromethorphan Hydrobromide alternatives are available?

Guaifenesin And Dextromethorphan Hydrobromide is a drug marketed by Aurobindo Pharma Ltd and Actavis Labs Fl and is included in two NDAs.

The generic ingredient in GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE is dextromethorphan hydrobromide; guaifenesin. There are twenty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.

Summary for Tradename: GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list25
Clinical Trials: see list104,401
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL206941-001Mar 17, 2017OTCNoNo► Subscribe► Subscribe
Actavis Labs Fl
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL091070-002Aug 31, 2015OTCNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL206941-002Mar 17, 2017OTCNoNo► Subscribe► Subscribe
Actavis Labs Fl
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL091070-001Aug 31, 2015OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Healthtrust
Argus Health
Fish and Richardson
US Department of Justice
Dow
Cipla
Queensland Health
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot